Quantcast

Latest early-stage breast cancer Stories

2010-12-03 07:00:00

REDWOOD CITY, Calif., Dec. 3, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from seven studies at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), taking place December 8-12, 2010 at the Henry B. Gonzalez Convention Center. All of the studies analyze the company's Oncotype DX® breast cancer test, which is a multi-gene expression test that physicians currently use to predict the...

2010-11-01 07:00:00

SAN DIEGO, Nov. 1, 2010 /PRNewswire/ -- Xoft, Inc., developer of the Axxent® Electronic Brachytherapy, eBx(TM) System, will showcase its industry leading multi-platform IORT (intraoperative radiation therapy) capabilities here at the 52nd American Society for Radiology and Oncology (ASTRO) Meeting, October 31 - November 4. The Axxent System, which delivers non-radioactive, electronic therapy directly to cancer sites with minimal radiation exposure to surrounding healthy...

2010-10-31 07:30:00

SUNNYVALE, Calif., Oct. 31 /PRNewswire/ -- Accuray Incorporated, (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today studies underway at two leading academic institutions using CyberKnife radiosurgery in breast cancer treatment. These two studies, from the University of Texas Southwestern and Fox Chase Cancer Center, will be presented at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Diego from October 31 to November 4....

2010-09-13 07:00:00

BARCELONA, Spain, Sept. 13 /PRNewswire/ -- Xoft, Inc., the pioneer of localized, isotope-free radiation treatment delivered in minimally-shielded clinical settings, today announced the introduction of the Axxent® Electronic Brachytherapy, eBx(TM) System to physicians and distributors in Europe. The Axxent eBx System, which delivers treatment directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, treats breast, endometrial and skin...

2010-08-05 14:05:36

The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines to define appropriate fractionation of whole breast irradiation (WBI), finding that hypofractionated (HF) WBI is effective for many patients with early-stage breast cancer. These guidelines are published in the International Journal of Radiation Oncology"¢Biology"¢Physics, the official journal of ASTRO. Studies have shown that WBI following breast conserving surgery lowers the risk of tumor...

2010-06-14 07:00:00

SUNNYVALE, Calif., June 14 /PRNewswire/ -- The clinical benefits of isotope-free electronic radiation therapy delivered directly to cancer sites with minimal exposure to surrounding healthy tissue continues to be substantiated by multiple publications, according to Xoft, Inc., developer of the Axxent® Electronic Brachytherapy, eBx(TM) System. The leading provider of FDA-cleared Electronic Brachytherapy Systems, Xoft provides systems for single-dose intraoperative...

2010-06-07 13:35:41

Growing body of data suggests Chronix's serum DNA assays may represent a new approach to diagnostics and prognostics in cancer and other diseases Chronix Biomedical today reported new data further demonstrating that its serum DNA blood tests have the potential to accurately detect early stage breast cancer and prostate cancer. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on circulating DNA fragments that are released into the bloodstream by damaged...

2010-06-05 14:00:00

CHICAGO, June 5 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented preliminary data that shows nitrogen-containing bisphosphonates, therapeutic agents used to promote bone health and inhibit resorption, may cause a slightly poorer survival rate in post-menopausal women with early stage breast cancer who take them for their anti-osteoporosis properties. The findings were announced today at the 2010 American Society of Clinical Oncology...

2010-05-20 17:00:00

REDWOOD CITY, Calif., May 20 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from six separate studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 4-8, 2010 at McCormick Place in Chicago. The studies include four oral presentations covering breast, colon and renal cancers. The company markets the widely-adopted Oncotype DX® breast cancer test, which is clinically...

2010-04-28 07:00:00

LAS VEGAS, April 28 /PRNewswire/ -- Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System to deliver intraoperative radiation therapy (IORT) is growing as clinical experience demonstrates the isotope-free cancer treatment platform is a patient and physician friendly alternative. Xoft will showcase a variety of IORT oncology applications at the 11th Annual Meeting of the American Society of Breast Surgeons here, April 28-May 2, 2010. In the...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'